New Member to the CCRA Board
CCRA welcomes Dr. Dajan O’Donnell to its Board as the representative for the Cancer Research Society, where he serves as the Director of Scientific Affairs and Partnerships. Dajan is a seasoned professional with recent experience at Exactis Innovation and a long tenure in the pharmaceutical industry. He has a PhD in neurology and neurosurgery.
New Funding Opportunity from CIHR
CIHR’s Health Effects of Vaping Catalyst Grant funding opportunity will support projects relevant to the following research areas:
- Youth vaping of nicotine, cannabinoid extracts, THC, and other compounds
- Short and/or long-term health effects of vaping (including lung inju... Read More »
CIHR’s Health Effects of Vaping Catalyst Grant funding opportunity will support projects relevant to the following research areas:
- Youth vaping of nicotine, cannabinoid extracts, THC, and other compounds
- Short and/or long-term health effects of vaping (including lung inju... Read More »
Canadian Strategy for Cancer Control (2019-2029)
The refreshed Canadian Strategy for Cancer Control is here. Based on input from more than 7,500 Canadians including healthcare leaders from across the country, the Strategy sets the course for a more equitable approach to cancer in Canada. No matter who we are or where we live, we should all have access to world-class ... Read More »
The refreshed Canadian Strategy for Cancer Control is here. Based on input from more than 7,500 Canadians including healthcare leaders from across the country, the Strategy sets the course for a more equitable approach to cancer in Canada. No matter who we are or where we live, we should all have access to world-class ... Read More »